Genmab A/S (GMAB)

Genmab Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	5,451	4,352	5,452	2,957	4,758	2,166
Other Operating Activities	207	3,028	-1,540	-729	1,675	-840
Operating Cash Flow	5,658	7,380	3,912	2,228	6,433	1,326
Operating Cash Flow Growth	-13.75%	88.65%	75.58%	-65.37%	385.14%	30.64%
Capital Expenditures	-300	-376	-317	-252	-307	-111
Change in Investments	-2,410	-906	-2,444	-709	-2,044	-1,872
Investing Cash Flow	-2,710	-1,282	-2,761	-961	-2,351	-1,983
Share Issuance / Repurchase	-566	-564	-908	-447	0	3,873
Debt Issued / Paid	-94	-91	-73	-58	-44	-31
Other Financing Activities	70	49	192	85	115	-182
Financing Cash Flow	-590	-606	-789	-420	71	3,660
Exchange Rate Effect	24	-518	574	850	-445	16
Net Cash Flow	2,358	5,492	362	847	4,153	3,003
Free Cash Flow	5,358	7,004	3,595	1,976	6,126	1,215
Free Cash Flow Growth	-13.52%	94.83%	81.93%	-67.74%	404.20%	126.26%
Free Cash Flow Margin	30.16%	42.52%	24.78%	23.48%	60.59%	22.64%
Free Cash Flow Per Share	8.11	10.60	5.46	3.01	9.41	1.89

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).